OncoSec Medical's Corporate Minority - P2P Round

OncoSec Medical raised a round of funding on September 04, 2018. Investors include Alpha Holdings.

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. OncoSec's lead i…

Articles about OncoSec Medical's Corporate Minority - P2P Round: